The European Commission has set the objective of reducing the incidence and impact of cancer. This mission is a defining framework for funding and research priorities. This webinar will explore an important dimension of how research in the field of photonics-enabled medical technology can play a role in helping reduce the health and economic costs of Europe's second most common cancer.
The webinar will hear three presentations:
- Colorectal Cancer in Europe: The Costs and the Challenges - Dr Stephen Capper (Q4 & PROSCOPE Consortium)
- Photonics and the Early Diagnosis of CRC - Prof Peter Andersen (Technical University of Denmark & PROSCOPE Consortium)
- Photonics and Europe's Health Challenges - Dr Thomas Mayerhofer (Leibniz Institute of Photonic Technologies & Photonics 21)
There will be extensive opportunity for questions during the webinar.
Bringing together 10 partners in 5 countries, PROSCOPE is a research consortium working to explore the potential to integrate optical imaging technics to allow for the early diagnosis and therefore treatment of colorectal cancer.